2285 related articles for article (PubMed ID: 17638928)
1. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
3. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
7. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
[TBL] [Abstract][Full Text] [Related]
8. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
10. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
Dembitsky WP; Tector AJ; Park S; Moskowitz AJ; Gelijns AC; Ronan NS; Piccione W; Holman WL; Furukawa S; Weinberg AD; Heatley G; Poirier VL; Damme L; Long JW
Ann Thorac Surg; 2004 Dec; 78(6):2123-9; discussion 2129-30. PubMed ID: 15561049
[TBL] [Abstract][Full Text] [Related]
12. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
[TBL] [Abstract][Full Text] [Related]
13. Risk factors predictive of right ventricular failure after left ventricular assist device implantation.
Drakos SG; Janicki L; Horne BD; Kfoury AG; Reid BB; Clayson S; Horton K; Haddad F; Li DY; Renlund DG; Fisher PW
Am J Cardiol; 2010 Apr; 105(7):1030-5. PubMed ID: 20346326
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular assist devices as destination therapy: a new look at survival.
Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
[TBL] [Abstract][Full Text] [Related]
15. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW;
J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613
[TBL] [Abstract][Full Text] [Related]
16. Preoperative risk factors for mortality after biventricular assist device implantation.
Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
[TBL] [Abstract][Full Text] [Related]
17. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
[TBL] [Abstract][Full Text] [Related]
18. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
[TBL] [Abstract][Full Text] [Related]
20. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
